MicroRNA-155 attenuates activation of hepatic stellate cell by simultaneously preventing EMT process and ERK1 signalling pathway

Liver Int. 2015 Apr;35(4):1234-43. doi: 10.1111/liv.12660. Epub 2014 Sep 15.

Abstract

Background & aims: Epithelial-mesenchymal transition (EMT) process and extracellular signal-regulated kinase 1 (ERK1) signalling pathway play pivotal roles in hepatic stellate cell (HSC) activation, which is associated with the altered expression patterns of microRNAs (miRNAs). miR-155 is considered a typical multifunctional miRNA to regulate many biological processes. However, little attention has been given to the contributions of miR-155 to simultaneous regulation of EMT process and ERK1 pathway during HSC activation.

Methods: Differential expression of miR-155 was assessed in activated HSC, sera and liver tissues from cirrhotic patients. Whether miR-155 could directly interact with 3'-untranslated region (3'-UTR) of T cell factor 4 (TCF4) and angiotensin II receptor type 1 (AGTR1) respectively was detected by luciferase reporter assay. The effects of enhanced miR-155 on EMT process and ERK1 pathway, cell apoptosis in HSC activation were also evaluated.

Results: A significant decrease in miR-155 expression was observed in activated HSC, sera or liver tissues of cirrhotic patients. MiR-155 was found to simultaneously interact with 3'-UTR of TCF4 and AGTR1 mRNAs, which are known as important regulators associated with EMT and ERK1 pathway repectively. Inhibiting miR-155 expression could stimulate the EMT state and ERK1 pathway activity, thus contributing to HSC activation. Forced miR-155 expression markedly decreased the mesenchymal markers and phosphorylated ERK1 level, and enhanced E-cadherin expression, leading to the synchronous inhibitory effect on EMT and ERK1 pathway and inducing HSC apoptosis.

Conclusions: Our results implicate that miR-155 plays an important role in regulating the pathological network involving EMT process and ERK1 pathway during HSC activation.

Keywords: epithelial-mesenchymal transition (EMT); extracellular signal-regulated kinase 1 (ERK1) signalling pathway; hepatic stellate cell (HSC); microRNA-155; regulation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3' Untranslated Regions
  • Animals
  • Apoptosis
  • Binding Sites
  • Case-Control Studies
  • DNA-Binding Proteins / genetics
  • DNA-Binding Proteins / metabolism
  • Epithelial-Mesenchymal Transition*
  • Gene Expression Regulation
  • HEK293 Cells
  • Hepatic Stellate Cells / enzymology*
  • Hepatic Stellate Cells / pathology
  • Humans
  • Liver / enzymology*
  • Liver / pathology
  • Liver Cirrhosis / enzymology*
  • Liver Cirrhosis / genetics
  • Liver Cirrhosis / pathology
  • Liver Cirrhosis, Experimental / enzymology*
  • Liver Cirrhosis, Experimental / genetics
  • Liver Cirrhosis, Experimental / pathology
  • MicroRNAs / genetics
  • MicroRNAs / metabolism*
  • Mitogen-Activated Protein Kinase 3 / metabolism*
  • Rats, Sprague-Dawley
  • Receptor, Angiotensin, Type 1 / genetics
  • Receptor, Angiotensin, Type 1 / metabolism
  • Signal Transduction*
  • Time Factors
  • Transcription Factor 4
  • Transcription Factors / genetics
  • Transcription Factors / metabolism
  • Transfection

Substances

  • 3' Untranslated Regions
  • DNA-Binding Proteins
  • MIRN155 microRNA, human
  • MIRN155 microRNA, rat
  • MicroRNAs
  • Receptor, Angiotensin, Type 1
  • Tcf4 protein, rat
  • Transcription Factor 4
  • Transcription Factors
  • Mitogen-Activated Protein Kinase 3